Annual report
9627.TEDINET S100WFSA
Period2024-05-01 → 2025-04-30
Filed2025-07-31
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥456.8bn | 2024-05-01 → 2025-04-30 | Cons. | Net sales |
| Revenue | ¥399.8bn | 2023-05-01 → 2024-04-30 | Cons. | Net sales |
| Revenue | ¥358.7bn | 2022-05-01 → 2023-04-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥316.2bn | 2021-05-01 → 2022-04-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥297.3bn | 2020-05-01 → 2021-04-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥16.9bn | 2024-05-01 → 2025-04-30 | Cons. | Operating income |
| Operating income | ¥20.4bn | 2023-05-01 → 2024-04-30 | Cons. | Operating income |
| Ordinary income | ¥18.1bn | 2024-05-01 → 2025-04-30 | Cons. | Ordinary income |
| Ordinary income | ¥21.4bn | 2023-05-01 → 2024-04-30 | Cons. | Ordinary income |
| Ordinary income | ¥17.1bn | 2022-05-01 → 2023-04-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.0bn | 2021-05-01 → 2022-04-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12.6bn | 2020-05-01 → 2021-04-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥16.7bn | 2024-05-01 → 2025-04-30 | Cons. | Income before income taxes |
| Profit before tax | ¥19.1bn | 2023-05-01 → 2024-04-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥9.3bn | 2024-05-01 → 2025-04-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.4bn | 2023-05-01 → 2024-04-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.2bn | 2022-05-01 → 2023-04-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.1bn | 2021-05-01 → 2022-04-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.7bn | 2020-05-01 → 2021-04-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥9.3bn | 2024-05-01 → 2025-04-30 | Cons. | Profit loss |
| Net income | ¥11.4bn | 2023-05-01 → 2024-04-30 | Cons. | Profit loss |
| Total assets | ¥311.9bn | at 2025-04-30 | Cons. | Assets |
| Total assets | ¥249.4bn | at 2024-04-30 | Cons. | Assets |
| Total assets | ¥231.8bn | at 2023-04-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥212.5bn | at 2022-04-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥203.7bn | at 2021-04-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥169.3bn | at 2025-04-30 | Cons. | Liabilities |
| Total liabilities | ¥114.0bn | at 2024-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥142.6bn | at 2025-04-30 | Cons. | Net assets |
| Net assets / equity | ¥135.4bn | at 2024-04-30 | Cons. | Net assets |
| Net assets / equity | ¥126.5bn | at 2023-04-30v | Cons. | Net assets |
| Net assets / equity | ¥119.0bn | at 2022-04-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥115.8bn | at 2021-04-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥26.9bn | at 2025-04-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥48.6bn | at 2024-04-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥26.7bn | at 2025-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥48.4bn | at 2024-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥46.2bn | at 2023-04-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥59.5bn | at 2022-04-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥55.0bn | at 2021-04-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥23.1bn | 2024-05-01 → 2025-04-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.0bn | 2023-05-01 → 2024-04-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥20.3bn | 2022-05-01 → 2023-04-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥26.2bn | 2021-05-01 → 2022-04-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14.9bn | 2020-05-01 → 2021-04-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥65.9bn | 2024-05-01 → 2025-04-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15.7bn | 2023-05-01 → 2024-04-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥22.3bn | 2022-05-01 → 2023-04-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13.9bn | 2021-05-01 → 2022-04-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.5bn | 2020-05-01 → 2021-04-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥21.1bn | 2024-05-01 → 2025-04-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.1bn | 2023-05-01 → 2024-04-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥11.2bn | 2022-05-01 → 2023-04-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.8bn | 2021-05-01 → 2022-04-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.6bn | 2020-05-01 → 2021-04-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥264.32 | 2024-05-01 → 2025-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥324.64 | 2023-05-01 → 2024-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥262.87 | 2022-05-01 → 2023-04-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.47 | 2021-05-01 → 2022-04-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥189.04 | 2020-05-01 → 2021-04-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥4,063.53 | at 2025-04-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,866.55 | at 2024-04-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,599.47 | at 2023-04-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,385.51 | at 2022-04-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,267.49 | at 2021-04-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 45.7% | at 2025-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.3% | at 2024-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-04-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2022-04-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.8% | at 2021-04-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.7% | 2024-05-01 → 2025-04-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2023-05-01 → 2024-04-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2022-05-01 → 2023-04-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2021-05-01 → 2022-04-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-05-01 → 2021-04-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 13,009 | at 2025-04-30 | Cons. | Number of employees |
| Employees | 11,474 | at 2024-04-30 | Cons. | Number of employees |
| Employees | 10,651 | at 2023-04-30v | Cons. | Number of employees |
| Employees | 9,568 | at 2022-04-30v | Cons. | Number of employees |
| Employees | 9,019 | at 2021-04-30d | Cons. | Number of employees |
| Revenue | ¥17.7bn | 2024-05-01 → 2025-04-30 | Standalone | Operating revenue1 |
| Revenue | ¥14.1bn | 2023-05-01 → 2024-04-30 | Standalone | Operating revenue1 |
| Revenue | ¥12.8bn | 2022-05-01 → 2023-04-30v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥11.5bn | 2021-05-01 → 2022-04-30v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥11.6bn | 2020-05-01 → 2021-04-30d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥7.2bn | 2024-05-01 → 2025-04-30 | Standalone | Operating income |
| Operating income | ¥5.1bn | 2023-05-01 → 2024-04-30 | Standalone | Operating income |
| Ordinary income | ¥7.2bn | 2024-05-01 → 2025-04-30 | Standalone | Ordinary income |
| Ordinary income | ¥5.3bn | 2023-05-01 → 2024-04-30 | Standalone | Ordinary income |
| Ordinary income | ¥5.0bn | 2022-05-01 → 2023-04-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.2bn | 2021-05-01 → 2022-04-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.3bn | 2020-05-01 → 2021-04-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥7.2bn | 2024-05-01 → 2025-04-30 | Standalone | Income before income taxes |
| Profit before tax | ¥5.1bn | 2023-05-01 → 2024-04-30 | Standalone | Income before income taxes |
| Net income | ¥6.9bn | 2024-05-01 → 2025-04-30 | Standalone | Profit loss |
| Net income | ¥4.9bn | 2023-05-01 → 2024-04-30 | Standalone | Profit loss |
| Net income | ¥4.9bn | 2022-05-01 → 2023-04-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.0bn | 2021-05-01 → 2022-04-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.1bn | 2020-05-01 → 2021-04-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥181.7bn | at 2025-04-30 | Standalone | Assets |
| Total assets | ¥146.2bn | at 2024-04-30 | Standalone | Assets |
| Total assets | ¥143.8bn | at 2023-04-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥140.2bn | at 2022-04-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥136.4bn | at 2021-04-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥93.6bn | at 2025-04-30 | Standalone | Liabilities |
| Total liabilities | ¥62.7bn | at 2024-04-30 | Standalone | Liabilities |
| Net assets / equity | ¥88.1bn | at 2025-04-30 | Standalone | Net assets |
| Net assets / equity | ¥83.5bn | at 2024-04-30 | Standalone | Net assets |
| Net assets / equity | ¥81.3bn | at 2023-04-30v | Standalone | Net assets |
| Net assets / equity | ¥78.2bn | at 2022-04-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥77.3bn | at 2021-04-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥9.3bn | at 2025-04-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥34.0bn | at 2024-04-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥197.89 | 2024-05-01 → 2025-04-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥140.65 | 2023-05-01 → 2024-04-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥139.46 | 2022-05-01 → 2023-04-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥141.15 | 2021-05-01 → 2022-04-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.16 | 2020-05-01 → 2021-04-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥80 | 2024-05-01 → 2025-04-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2023-05-01 → 2024-04-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2022-05-01 → 2023-04-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2021-05-01 → 2022-04-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2020-05-01 → 2021-04-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,512.96 | at 2025-04-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,386.57 | at 2024-04-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,313.07 | at 2023-04-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,227.25 | at 2022-04-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,180.74 | at 2021-04-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 48.5% | at 2025-04-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.1% | at 2024-04-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.5% | at 2023-04-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.8% | at 2022-04-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.6% | at 2021-04-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.1% | 2024-05-01 → 2025-04-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2023-05-01 → 2024-04-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2022-05-01 → 2023-04-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2021-05-01 → 2022-04-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2020-05-01 → 2021-04-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 35,428,212 | at 2025-04-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2024-04-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2023-04-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2022-04-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2021-04-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 169 | at 2025-04-30 | Standalone | Number of employees |
| Employees | 162 | at 2024-04-30 | Standalone | Number of employees |
| Employees | 161 | at 2023-04-30v | Standalone | Number of employees |
| Employees | 160 | at 2022-04-30v | Standalone | Number of employees |
| Employees | 156 | at 2021-04-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 66
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2024-05-01 → 2025-04-30 | ¥80m |
| Otherother segments | depreciation | 2024-05-01 → 2025-04-30 | ¥318m |
| Otherother segments | revenue | 2024-05-01 → 2025-04-30 | ¥11.0bn |
| Otherother segments | revenue external | 2024-05-01 → 2025-04-30 | ¥11.0bn |
| Otherother segments | revenue intersegment | 2024-05-01 → 2025-04-30 | ¥54m |
| Otherother segments | segment assets | at 2025-04-30 | ¥9.8bn |
| Otherother segments | segment ordinary income | 2024-05-01 → 2025-04-30 | ¥4m |
| Reconciling Itemsreconciling | capex | 2024-05-01 → 2025-04-30 | ¥2.8bn |
| Reconciling Itemsreconciling | depreciation | 2024-05-01 → 2025-04-30 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2024-05-01 → 2025-04-30 | −¥54m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-05-01 → 2025-04-30 | −¥54m |
| Reconciling Itemsreconciling | segment assets | at 2025-04-30 | ¥51.4bn |
| Reconciling Itemsreconciling | segment ordinary income | 2024-05-01 → 2025-04-30 | −¥11.0bn |
| Dispensing Pharmacyreportable segment | capex | 2024-05-01 → 2025-04-30 | ¥7.2bn |
| Dispensing Pharmacyreportable segment | depreciation | 2024-05-01 → 2025-04-30 | ¥4.2bn |
| Dispensing Pharmacyreportable segment | employees | at 2025-04-30 | 11119 pure |
| Dispensing Pharmacyreportable segment | revenue | 2024-05-01 → 2025-04-30 | ¥384.8bn |
| Dispensing Pharmacyreportable segment | revenue external | 2024-05-01 → 2025-04-30 | ¥384.8bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2025-04-30 | ¥216.8bn |
| Dispensing Pharmacyreportable segment | segment ordinary income | 2024-05-01 → 2025-04-30 | ¥24.3bn |
| Drug And Cosmetic Storereportable segment | capex | 2024-05-01 → 2025-04-30 | ¥2.4bn |
| Drug And Cosmetic Storereportable segment | depreciation | 2024-05-01 → 2025-04-30 | ¥1.3bn |
| Drug And Cosmetic Storereportable segment | employees | at 2025-04-30 | 1231 pure |
| Drug And Cosmetic Storereportable segment | revenue | 2024-05-01 → 2025-04-30 | ¥61.0bn |
| Drug And Cosmetic Storereportable segment | revenue external | 2024-05-01 → 2025-04-30 | ¥61.0bn |
| Drug And Cosmetic Storereportable segment | segment assets | at 2025-04-30 | ¥34.0bn |
| Drug And Cosmetic Storereportable segment | segment ordinary income | 2024-05-01 → 2025-04-30 | ¥4.8bn |
| —segment total | capex | 2024-05-01 → 2025-04-30 | ¥9.7bn |
| —segment total | depreciation | 2024-05-01 → 2025-04-30 | ¥5.9bn |
| —segment total | revenue | 2024-05-01 → 2025-04-30 | ¥456.9bn |
| —segment total | revenue external | 2024-05-01 → 2025-04-30 | ¥456.8bn |
| —segment total | revenue intersegment | 2024-05-01 → 2025-04-30 | ¥54m |
| —segment total | segment assets | at 2025-04-30 | ¥260.5bn |
| —segment total | segment ordinary income | 2024-05-01 → 2025-04-30 | ¥29.1bn |
| Otherother segments | capex | 2023-05-01 → 2024-04-30 | ¥1.0bn |
| Otherother segments | depreciation | 2023-05-01 → 2024-04-30 | ¥279m |
| Otherother segments | revenue | 2023-05-01 → 2024-04-30 | ¥11.2bn |
| Otherother segments | revenue external | 2023-05-01 → 2024-04-30 | ¥11.1bn |
| Otherother segments | revenue intersegment | 2023-05-01 → 2024-04-30 | ¥54m |
| Otherother segments | segment assets | at 2024-04-30 | ¥10.4bn |
| Otherother segments | segment ordinary income | 2023-05-01 → 2024-04-30 | ¥47m |
| Reconciling Itemsreconciling | capex | 2023-05-01 → 2024-04-30 | ¥2.3bn |
| Reconciling Itemsreconciling | depreciation | 2023-05-01 → 2024-04-30 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2023-05-01 → 2024-04-30 | −¥54m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-05-01 → 2024-04-30 | −¥54m |
| Reconciling Itemsreconciling | segment assets | at 2024-04-30 | ¥3.9bn |
| Reconciling Itemsreconciling | segment ordinary income | 2023-05-01 → 2024-04-30 | −¥9.4bn |
| Dispensing Pharmacyreportable segment | capex | 2023-05-01 → 2024-04-30 | ¥8.0bn |
| Dispensing Pharmacyreportable segment | depreciation | 2023-05-01 → 2024-04-30 | ¥3.7bn |
| Dispensing Pharmacyreportable segment | revenue | 2023-05-01 → 2024-04-30 | ¥357.6bn |
| Dispensing Pharmacyreportable segment | revenue external | 2023-05-01 → 2024-04-30 | ¥357.6bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2024-04-30 | ¥219.7bn |
| Dispensing Pharmacyreportable segment | segment ordinary income | 2023-05-01 → 2024-04-30 | ¥27.6bn |
| Drug And Cosmetic Storereportable segment | capex | 2023-05-01 → 2024-04-30 | ¥1.4bn |
| Drug And Cosmetic Storereportable segment | depreciation | 2023-05-01 → 2024-04-30 | ¥438m |
| Drug And Cosmetic Storereportable segment | revenue | 2023-05-01 → 2024-04-30 | ¥31.1bn |
| Drug And Cosmetic Storereportable segment | revenue external | 2023-05-01 → 2024-04-30 | ¥31.1bn |
| Drug And Cosmetic Storereportable segment | segment assets | at 2024-04-30 | ¥15.4bn |
| Drug And Cosmetic Storereportable segment | segment ordinary income | 2023-05-01 → 2024-04-30 | ¥3.1bn |
| —segment total | capex | 2023-05-01 → 2024-04-30 | ¥10.5bn |
| —segment total | depreciation | 2023-05-01 → 2024-04-30 | ¥4.4bn |
| —segment total | revenue | 2023-05-01 → 2024-04-30 | ¥399.9bn |
| —segment total | revenue external | 2023-05-01 → 2024-04-30 | ¥399.8bn |
| —segment total | revenue intersegment | 2023-05-01 → 2024-04-30 | ¥54m |
| —segment total | segment assets | at 2024-04-30 | ¥245.5bn |
| —segment total | segment ordinary income | 2023-05-01 → 2024-04-30 | ¥30.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,668
| Item | Context | Value | Unit |
|---|---|---|---|
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | Text · Plus | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)㈱ほくほくフィナンシャルグループ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)重要な資金借入先であり資金調達の安定と、同行からの情報を通じて当社グループの効率的な事業展開を図るため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)㈱北洋銀行 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)重要な資金借入先であり資金調達の安定と、同行からの情報を通じて当社グループの効率的な事業展開を図るため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)塩野義製薬㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)業界動向把握のため保有しており、配当金およびその企業に係る収益などをもとに保有効果を見込んでいるため（注）１ | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)㈱エコノス | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)当社との協力関係の維持強化のため保有しており、配当金およびその企業に係る収益などをもとに保有効果を見込んでいるため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)㈱エコミック | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)重要な取引先であり、同社からの給与計算等のサービス提供を通じて事業活動の円滑化を図るため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)太平洋興発㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)当社との協力関係の維持強化のため保有しており、配当金およびその企業に係る収益などをもとに保有効果を見込んでいるため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)スパークス・グループ㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)当社との協力関係の維持強化のため保有しており、配当金およびその企業に係る収益などをもとに保有効果を見込んでいるため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)㈱みずほフィナンシャルグループ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)重要な資金借入先であり資金調達の安定と、同行からの情報を通じて当社グループの効率的な事業展開を図るため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)無 | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row1Member | Text · Plus | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row2Member | Text · Plus | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row3Member | Text · Plus | |
| Name of securities details of deemed holdings of equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)㈱トーカイ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of deemed holdings of shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)退職給付信託に拠出しており、議決権行使の指図権は留保資本・業務提携を通じて当社グループの効率的な事業展開を図るため保有 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of deemed holdings of shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)有 | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Changes in scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |